XML 25 R8.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Cash flows from operating activities:      
Net cash provided by operating activities   $ 273,980 $ 173,545
Cash flows from investing activities:      
Proceeds from sale of property and equipment   32 141
Purchases of property and equipment   (4,880) (14,580)
Purchases of equity securities   (46,532) (11,145)
Purchases of available-for-sale debt securities   (354,907) (735,426)
Purchases of investment real estate, net   (7) (6)
Proceeds from sales of equity securities $ 48,486 53,651 0
Proceeds from sales of available-for-sale debt securities   76,516 757,812
Proceeds from sales of investment real estate   2,591 0
Proceeds from sale of assets held for sale   8,856 0
Maturities of available-for-sale debt securities   70,095 115,543
Net cash provided by (used in) investing activities   (194,585) 112,339
Cash flows from financing activities:      
Preferred stock dividend   (8) (8)
Common stock dividend   (15,104) (15,516)
Purchase of treasury stock   (1,609) (26,501)
Payments related to tax withholding for share-based compensation   (784) (1,253)
Repayment of debt   (1,103) (1,103)
Net cash provided by (used in) financing activities   (18,608) (44,381)
Cash and cash equivalents, and restricted cash and cash equivalents:      
Net increase (decrease) during the period   60,787 241,503
Balance, beginning of period   179,871 184,744
Balance, end of period 240,658 240,658 426,247
Cash and cash equivalents, and restricted cash and cash equivalents within the Consolidated Balance Sheets      
Cash and cash equivalents 224,822 224,822  
Restricted cash and cash equivalents 15,836 [1] 15,836 [1]  
Total cash and cash equivalents and restricted cash and cash equivalents $ 240,658 $ 240,658 $ 426,247
[1] See “—Note 5 (Insurance Operations)” for a discussion of the nature of the restrictions for restricted cash and cash equivalents and “—Note 14 (Variable Interest Entities)” for a discussion of restricted cash held in a trust account.